TENOFOVIR ALAFENAMIDE for Acquired immunodeficiency syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where TENOFOVIR ALAFENAMIDE was used for Acquired immunodeficiency syndrome.
Most Reported Side Effects for TENOFOVIR ALAFENAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 217 | 7.3% | 214 | 2 |
| Product dose omission issue | 153 | 5.1% | 4 | 18 |
| Off label use | 96 | 3.2% | 8 | 31 |
| Drug ineffective | 93 | 3.1% | 5 | 13 |
| Fatigue | 92 | 3.1% | 1 | 8 |
| Headache | 71 | 2.4% | 0 | 6 |
| Product dose omission | 69 | 2.3% | 0 | 2 |
| Intentional dose omission | 67 | 2.2% | 0 | 5 |
| Product use issue | 67 | 2.2% | 0 | 6 |
| Nausea | 64 | 2.1% | 1 | 7 |
| Diarrhoea | 60 | 2.0% | 4 | 21 |
| Maternal exposure during pregnancy | 58 | 1.9% | 0 | 4 |
| Foetal exposure during pregnancy | 52 | 1.7% | 7 | 9 |
| Neoplasm malignant | 52 | 1.7% | 9 | 11 |
| Hepatitis b | 48 | 1.6% | 3 | 16 |
Other Indications for TENOFOVIR ALAFENAMIDE
Hepatitis b (935)
Product used for unknown indication (757)
Chronic hepatitis b (679)
Hiv infection (197)
Hepatitis viral (38)
Acute hepatitis b (36)
Antiretroviral therapy (24)
Hepatic cirrhosis (23)
Hepatitis b reactivation (21)
Viral hepatitis carrier (12)
Other Drugs Used for Acquired immunodeficiency syndrome
EMTRICITABINE\TENOFOVIR DISOPROXIL (711)
TENOFOVIR DISOPROXIL (636)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (536)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (446)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (427)
LAMIVUDINE (364)
EFAVIRENZ (191)
DOLUTEGRAVIR (149)
RITONAVIR (147)
LOPINAVIR\RITONAVIR (125)